pharma · Idiopathic Pulmonary Fibrosis · Idiopathic pulmonary fibrosis (IPF) · PLRX
PLIANT THERAPEUTICS
PLIANT THERAPEUTICS, INC.
Pliant Therapeutics is a pharma organization headquartered in South San Francisco, USA. It trades on NYSE under ticker PLRX. Primary therapeutic focus areas include Idiopathic Pulmonary Fibrosis, Idiopathic pulmonary fib
South San Francisco, USA HQ
2015 Founded
122 Employees
Public company Type
PLRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2015
- Employees
- 122
- Programs
- 6
- Drugs
- 3
- Patents
- 13
Bexotegrast, Placebo matching PLN-74809
Phase 3 · small molecule · Idiopathic pulmonary fibrosis (IPF)
Bexotegrast, Placebo matching PLN-74809 for Idiopathic pulmonary fibrosis (IPF) is a Phase 3 program (small_molecule) at PLIANT THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code PLN-74809-IPF-206
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- PLIANT THERAPEUTICS, INC.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Idiopathic pulmonary fibrosis (IPF)
- Status
- active
- Trials
- 1